Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study

Human papillomavirus (HPV) types 16/18, included in HPV vaccines, contribute to the majority of cervical cancer, and a substantial proportion of cervical intraepithelial neoplasia (CIN) grades 2/3 or worse (CIN2+/CIN3+) including adenocarcinoma in situ or worse. The aim of this study was to quantify...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2016-06, Vol.138 (12), p.2867-2874
Hauptverfasser:	Herweijer, Eva, Sundström, Karin, Ploner, Alexander, Uhnoo, Ingrid, Sparén, Pär, Arnheim‐Dahlström, Lisen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Distribution Cancer Cancer Epidemiology Cervical cancer Cohort Studies Female high‐grade cervical lesions HPV vaccination Human papillomavirus Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - immunology Humans Immunization Medical research Medical screening nationwide Papillomavirus Infections - immunology Papillomavirus Infections - prevention & control Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology Vaccination vaccine effectiveness Vaccine Potency Vaccines Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!